Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21453488 | 0.90 | KDM4E (0.32) | KDM4ETSHRHSD17B10L3MBTL1ATM | |
| SCHEMBL21453658 | 0.90 | KDM4E (0.31) | KDM4ETSHRHSD17B10 | |
| SCHEMBL20071688 | 0.89 | KDM4E (0.32) | KDM4ETSHRHSD17B10L3MBTL1ATM | |
| SCHEMBL20071636 | 0.89 | KDM4E (0.33) | KDM4ETSHRHSD17B10L3MBTL1ATM | |
| SCHEMBL10027515 | 0.88 | L3MBTL1 (0.36) | KDM4EL3MBTL1ATMMEN1KMT2A | |
| SCHEMBL21453669 | 0.88 | — | — | |
| SCHEMBL21453481 | 0.88 | KDM4E (0.32) | KDM4ETSHRHSD17B10L3MBTL1ATM | |
| SCHEMBL23474712 | 0.87 | KDM4E (0.33) | KDM4ETSHRHSD17B10L3MBTL1ATM | |
| SCHEMBL21449214 | 0.87 | KDM4E (0.33) | KDM4ETSHRHSD17B10L3MBTL1ATM | |
| SCHEMBL21454098 | 0.87 | KDM4E (0.35) | KDM4ETSHRHSD17B10L3MBTL1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11038121-B2 | 9 membered ring carbazole compounds | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-06-15 | — | — | US | disclosed |
| US-20190312214-A1 | 9 MEMBERED RING CARBAZOLE COMPOUNDS | BEIJING SUMMER SPROUT TECHNOLOGY CO., LTD (CN) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11038121-B2 | 9 membered ring carbazole compounds | SLC25A21, OCIAD2, OXA1L | KDM4E 3723/4885TSHR 4332/4885HSD17B10 1511/4885 |
| US-20190312214-A1 | 9 MEMBERED RING CARBAZOLE COMPOUNDS | SLC25A21, OCIAD2, OXA1L | KDM4E 3723/4885TSHR 4332/4885HSD17B10 1511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.